Inhaled insulin was as effective as rapid acting analog insulin in improving A1C and fared better in reducing body weight, fasting plasma glucose and hypoglycemic events in type 1 diabetes patients, researchers reported at the ADA 74th Scientific Sessions. The treatment also outperformed placebo in regulating postmeal glucose spikes in insulin-naive type 2 diabetes patients, another study showed.

Related Summaries